Skip to content
healthcare.dev

EMEND

NDC 0006-3061, FOSAPREPITANT DIMEGLUMINE, injection, powder, lyophilized, for solution, from Merck Sharp & Dohme LLC.

Product NDC
0006-3061
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022023
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3061 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FOSAPREPITANT DIMEGLUMINE150 mg/5mL

Pharmacologic classes

Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
0006-3061-00000063061001 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00) / 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8d66803a-6811-4c29-9c57-e16acfa87f21
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0006-3061

Use it

Look up 0006-3061 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0006-3061 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0006-3061. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.